Osaka, Japan

Yosuke Takanashi

This inventor holds 10 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., International Institute of Cancer Immunology, Inc., Sumitomo Pharma Co., Ltd.. Active years: 2015-2025.

USPTO Granted Patents = 10 

% Patents Active = 70.0

 

 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Yosuke Takanashi

Introduction

Yosuke Takanashi, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of biotechnology. With a portfolio of eight patents, Takanashi's work focuses on developing innovative solutions for cancer therapies, showcasing his dedication to advancing medical science.

Latest Patents

Among Takanashi's latest patents are groundbreaking inventions including "Antibody-drug conjugates including hemiasterlin derivative," which introduces a compound structured as specified in his documentation, where unique variables indicate the flexibility in the molecular design. Another notable patent is the "WT1 antigen peptide conjugate vaccine," representing advancements in antigen-specific immunotherapy, where intricate formulations include various MHC class I and II restricted peptides. These inventions not only reflect Takanashi's scientific ingenuity but also highlight the importance of targeted treatments in modern medicine.

Career Highlights

Throughout his career, Takanashi has been affiliated with reputable organizations, including Sumitomo Dainippon Pharma Co., Ltd and the International Institute of Cancer Immunology, Inc. His work at these institutions underscores his commitment to bringing clinical innovations to market, striving to improve outcomes for cancer patients through enhanced therapeutic modalities.

Collaborations

Takanashi has collaborated with esteemed scientists like Hitoshi Ban and Yukihiro Nishio, enriching his research and development initiatives. These partnerships have facilitated the exchange of ideas and fostered an environment conducive to innovation, further enhancing the potential impact of his patented inventions on cancer therapy.

Conclusion

Yosuke Takanashi stands out as a notable inventor in the realm of biotechnology, with a strong focus on developing targeted cancer treatments. His ongoing work and collaborations continue to pave the way for future innovations that could transform cancer therapy and improve the lives of countless patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…